Viewing Study NCT06078657


Ignite Creation Date: 2025-12-24 @ 7:09 PM
Ignite Modification Date: 2025-12-29 @ 12:43 AM
Study NCT ID: NCT06078657
Status: UNKNOWN
Last Update Posted: 2023-10-12
First Post: 2023-09-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: IBI110 Combined With Sintilimab in Second-line Advanced or Metastatic Esophageal Squamous Cell Carcinoma(ESCC)
Sponsor: The First Affiliated Hospital of Zhengzhou University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module